Daiken Medical Co., Ltd. (7775.T)
JPY 513.0
(-0.58%)
JPY 513.0
(-0.58%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.65 Billion JPY | 25.2% |
| 2022 | 1.29 Billion JPY | -9.9% |
| 2021 | 1.47 Billion JPY | 20.78% |
| 2020 | 1.18 Billion JPY | -17.05% |
| 2019 | 1.45 Billion JPY | -5.52% |
| 2018 | 1.46 Billion JPY | -11.71% |
| 2017 | 1.61 Billion JPY | -7.09% |
| 2016 | 1.88 Billion JPY | 0.0% |
| 2015 | 1.9 Billion JPY | 6.19% |
| 2014 | 1.76 Billion JPY | 11.94% |
| 2013 | 1.58 Billion JPY | 5.48% |
| 2012 | 1.51 Billion JPY | 13.53% |
| 2011 | 1.31 Billion JPY | 4.8% |
| 2010 | 1.23 Billion JPY | 17.44% |
| 2009 | 1.06 Billion JPY | 28.23% |
| 2008 | 828.58 Million JPY | 22.56% |
| 2007 | 687.82 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 450.5 Million JPY | 74.58% |
| 2024 Q2 | 497.95 Million JPY | 10.53% |
| 2023 Q4 | 263.43 Million JPY | -46.67% |
| 2023 FY | - JPY | 25.2% |
| 2023 Q1 | 343.1 Million JPY | 300.01% |
| 2023 Q2 | 407.32 Million JPY | 18.72% |
| 2023 Q3 | 493.95 Million JPY | 21.27% |
| 2022 Q4 | 85.77 Million JPY | -76.49% |
| 2022 Q1 | 289.1 Million JPY | 31.66% |
| 2022 Q2 | 317.89 Million JPY | 9.96% |
| 2022 FY | - JPY | -9.9% |
| 2022 Q3 | 364.82 Million JPY | 14.76% |
| 2021 Q3 | 369.2 Million JPY | 16.53% |
| 2021 FY | - JPY | 20.78% |
| 2021 Q1 | 250.5 Million JPY | 231.43% |
| 2021 Q2 | 316.82 Million JPY | 26.48% |
| 2021 Q4 | 219.58 Million JPY | -40.53% |
| 2020 Q2 | 298.34 Million JPY | 55.12% |
| 2020 Q1 | 192.33 Million JPY | -19.12% |
| 2020 FY | - JPY | -17.05% |
| 2020 Q3 | 394.77 Million JPY | 32.32% |
| 2020 Q4 | 75.58 Million JPY | -80.85% |
| 2019 Q4 | 237.79 Million JPY | -39.72% |
| 2019 Q2 | 255.52 Million JPY | -21.82% |
| 2019 Q3 | 394.49 Million JPY | 54.39% |
| 2019 Q1 | 326.84 Million JPY | 120.49% |
| 2019 FY | - JPY | -5.52% |
| 2018 Q1 | 351.82 Million JPY | 54.83% |
| 2018 FY | - JPY | -11.71% |
| 2018 Q4 | 148.23 Million JPY | -62.67% |
| 2018 Q2 | 353.56 Million JPY | 0.49% |
| 2018 Q3 | 397.13 Million JPY | 12.32% |
| 2017 Q1 | 418.89 Million JPY | 16.21% |
| 2017 Q3 | 446.1 Million JPY | 7.09% |
| 2017 FY | - JPY | -7.09% |
| 2017 Q4 | 227.23 Million JPY | -49.06% |
| 2017 Q2 | 416.55 Million JPY | -0.56% |
| 2016 Q3 | 502.21 Million JPY | 9.99% |
| 2016 Q1 | 398.76 Million JPY | 8.26% |
| 2016 FY | - JPY | 0.0% |
| 2016 Q4 | 360.47 Million JPY | -28.22% |
| 2016 Q2 | 456.61 Million JPY | 14.51% |
| 2015 Q2 | 419.61 Million JPY | -0.1% |
| 2015 Q4 | 368.33 Million JPY | -26.68% |
| 2015 FY | - JPY | 6.19% |
| 2015 Q1 | 420.01 Million JPY | 21.71% |
| 2015 Q3 | 502.35 Million JPY | 19.72% |
| 2014 Q3 | 500.54 Million JPY | 17.64% |
| 2014 FY | - JPY | 11.94% |
| 2014 Q1 | 357.02 Million JPY | 35.28% |
| 2014 Q2 | 425.47 Million JPY | 19.17% |
| 2014 Q4 | 345.09 Million JPY | -31.06% |
| 2013 Q3 | 462.33 Million JPY | 26.12% |
| 2013 Q1 | 313.8 Million JPY | 28.95% |
| 2013 FY | - JPY | 5.48% |
| 2013 Q4 | 263.92 Million JPY | -42.91% |
| 2013 Q2 | 366.57 Million JPY | 16.82% |
| 2012 Q1 | 248.84 Million JPY | -10.04% |
| 2012 FY | - JPY | 13.53% |
| 2012 Q4 | 243.34 Million JPY | -44.53% |
| 2012 Q3 | 438.66 Million JPY | 33.2% |
| 2012 Q2 | 329.32 Million JPY | 32.34% |
| 2011 Q2 | 253.66 Million JPY | 31.49% |
| 2011 Q1 | 192.9 Million JPY | -27.83% |
| 2011 FY | - JPY | 4.8% |
| 2011 Q4 | 276.61 Million JPY | -9.28% |
| 2011 Q3 | 304.91 Million JPY | 20.21% |
| 2010 Q1 | 219.06 Million JPY | -19.49% |
| 2010 Q2 | 251.84 Million JPY | 14.97% |
| 2010 Q3 | 375.24 Million JPY | 48.99% |
| 2010 FY | - JPY | 17.44% |
| 2010 Q4 | 267.29 Million JPY | -28.77% |
| 2009 Q4 | 272.1 Million JPY | -19.04% |
| 2009 Q1 | 223.89 Million JPY | 230.59% |
| 2009 Q3 | 336.08 Million JPY | 35.0% |
| 2009 FY | - JPY | 28.23% |
| 2009 Q2 | 248.94 Million JPY | 11.19% |
| 2008 FY | - JPY | 22.56% |
| 2008 Q3 | 275.44 Million JPY | 0.0% |
| 2008 Q4 | 67.72 Million JPY | -75.41% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| JINS HOLDINGS Inc. | 10.26 Billion JPY | 83.846% |
| Medius Holdings Co., Ltd. | 3.86 Billion JPY | 57.094% |
| Ship Healthcare Holdings, Inc. | 31.88 Billion JPY | 94.801% |
| JTEC Corporation | 437.18 Million JPY | -279.119% |
| Hogy Medical Co.,Ltd. | 10.77 Billion JPY | 84.619% |
| Kawamoto Corporation | 944.44 Million JPY | -75.492% |
| Terumo Corporation | 219.66 Billion JPY | 99.245% |
| KAINOS Laboratories, Inc. | 1.05 Billion JPY | -56.987% |
| JAPAN EYEWEAR HOLDINGS CO LTD | 5.18 Billion JPY | 68.022% |
| Sysmex Corporation | 115.67 Billion JPY | 98.567% |
| JMS Co.,Ltd. | 3.44 Billion JPY | 51.903% |
| Nakanishi Inc. | 32.3 Billion JPY | 94.869% |
| Mani, Inc. | 10.69 Billion JPY | 84.509% |
| Olympus Corporation | 180.16 Billion JPY | 99.08% |
| HOYA Corporation | 260.44 Billion JPY | 99.364% |
| SEED Co.,Ltd. | 4.88 Billion JPY | 66.04% |
| Asahi Intecc Co., Ltd. | 31.85 Billion JPY | 94.797% |
| Medikit Co.,Ltd. | 6.31 Billion JPY | 73.774% |
| Menicon Co., Ltd. | 16.9 Billion JPY | 90.193% |
| Sincere Co., LTD. | 391 Million JPY | -323.895% |
| Platz Co., Ltd. | 267.15 Million JPY | -520.407% |
| Paramount Bed Holdings Co., Ltd. | 23.4 Billion JPY | 92.92% |
| Shofu Inc. | 5.87 Billion JPY | 71.803% |
| Shigematsu Works Co., Ltd. | 1.38 Billion JPY | -19.649% |
| Nipro Corporation | 81.2 Billion JPY | 97.959% |
| ASO International, Inc. | 602.47 Million JPY | -175.104% |